2018. Evaluation of UHRF1 and P16INK4A expression levels in newly diagnosed AML patients. Biomedical Research and Therapy. 5, 9 (Sep. 2018), 2658–2663. DOI:https://doi.org/10.15419/bmrat.v5i9.475.